Search

everythinglearnresearchcommunity

for

Search:↓

Lanadelumab greatly reduces hospital visits and angioedema episodes, improving life quality for hereditary angioedema patients.

Hyaluronic acid fillers and combination treatments significantly improve facial defects from autoimmune diseases and are well-tolerated.

Etanercept effectively treated a severe skin condition when other treatments failed.

Human TMEM2 does not break down hyaluronan but helps control its metabolism.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Adding baricitinib will increase costs but offers more treatment options for alopecia areata.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Dupilumab may help treat alopecia areata, but more research is needed.

Belimumab may cause hair loss in lupus patients.

Secukinumab treatment may cause HBV reactivation and hair discoloration.

Belimumab effectively controls SLE disease activity and reduces steroid use.

A 29-year-old woman with symptoms of both lupus and rheumatoid arthritis improved with specific medications.

Monoclonal antibodies are often linked to alopecia areata cases.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.

Monitor for early signs of azathioprine toxicity and check blood counts regularly.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Dupilumab for skin problems might reactivate hair loss in some patients.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

Ixekizumab quickly and effectively clears palmoplantar psoriasis in both adults and children.

A woman's hair grew back while she was taking sulphasalazine for arthritis.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.